Editorial Commentary
Local consolidative therapy for oligometastatic non-small cell lung cancer
Abstract
The concept of local consolidative therapy (LCT) for oligometastatic non-small cell lung cancer (NSCLC) using radiation therapy and/or surgical resection has been present for approximately two decades (1-3). However, data supporting this approach has evolved from single-institution retrospective series (which can be influenced by selection bias) to multi-institutional randomized studies.
